Knowledge About Tuberculosis and Multi-Drug Resistant Tuberculosis Among Interns

Background: Tuberculosis (TB) is an ancient disease with new threats of Multi-drug resistant (MDR-TB) and Extensively drug resistant tuberculosis (XDR-TB). To treat and prevent this every health care personnel should have a thorough knowledge of it. Internship is a crucial period when knowledge is...

Full description

Bibliographic Details
Published in:	National Journal of Community Medicine
Main Authors:	Rupali A Patel, Gautam M Khakse
Format:	Article
Language:	English
Published:	Medsci Publications 2014-03-01
Subjects:	Interns Tuberculosis MDR-TB XDR-TB DOTS RNTCP
Online Access:	https://njcmindia.com/index.php/file/article/view/1314

Similar Items

Issues of Tuberculosis Drug-Resistance in Kharkiv Region and in Ukraine
by: O.S. Shevchenko, et al.
Published: (2019-11-01)

Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients
by: Fahmida Rahman, et al.
Published: (2013-01-01)

Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyResearch in context
by: Yousra Kherabi, et al.
Published: (2025-09-01)

Outcomes of bedaquiline containing regimen in the treatment of adults with drug resistant tuberculosis in a tertiary care centre of Rajasthan
by: Roshni Mary Prince, et al.
Published: (2023-08-01)

Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
by: Jaksuwan R, et al.
Published: (2017-06-01)

Drug-resistant tuberculosis: an experience from Qatar
by: Maisa Ali, et al.
Published: (2020-01-01)

Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
by: Kristina Wallengren, et al.
Published: (2011-10-01)

Drug-Resistant Tuberculosis, Lebanon, 2016 – 2017
by: Salam El Achkar, et al.
Published: (2019-03-01)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
by: Cannas A, et al.
Published: (2019-10-01)

Exploring health care providers’ engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study
by: Bereket Aberham Lajore, et al.
Published: (2024-04-01)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
by: Benoît Henry, et al.
Published: (2016-03-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

THE ROLE OF THE IMPLANTABLE PORT SYSTEM FOR THE CENTRAL VENOUS ACCESS IN TREATMENT OF PULMONARY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVELY DRUG RESISTANCE (PRELIMINARY RESULTS)
by: О.R. RAZAKOV, et al.
Published: (2018-08-01)

Prevention of bronchial fistulas after pneumonectomies for selected cavitary drug resistant lung tuberculosis
by: Alexander V. Bazhenov, et al.
Published: (2023-03-01)

New drugs and perspectives for new anti-tuberculosis regimens☆
by: S. Tiberi, et al.
Published: (2018-03-01)

Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France
by: Isabelle Bonnet, et al.
Published: (2022-06-01)

Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil
by: Tania Matsui, et al.
Published: (2020-05-01)

Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
by: Xiaocui Wu, et al.
Published: (2019-11-01)

Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa
by: Alistair D. Calver, et al.
Published: (2010-02-01)

Tailored treatment for tuberculosis in transgender individuals: a call for a patient-centered approach from a large Italian cohort
by: Niccolò Riccardi, et al.
Published: (2024-01-01)

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen <i>Mycobacterium tuberculosis</i>
by: Giuseppe Mancuso, et al.
Published: (2023-09-01)

COMPARATIVE ANALYSIS OF MTB STRAINS WITH DIFFERENT TYPES OF DRUG RESISTANCE IN PULMONARY TUBERCULOSIS IN THE KYRGYZ REPUBLIC
by: A.A. TOKTOGONOVA, et al.
Published: (2018-08-01)

Impact of Delayed Video-Assisted Thoracoscopic Surgery on Pneumonectomy Outcomes in Patients with Tuberculosis
by: D. B. Giller, et al.
Published: (2025-05-01)

Communicable Episode 20: Tuberculosis today
by: Kathryn Hostettler, et al.
Published: (2025-06-01)

Treatment outcomes for drug-resistant tuberculosis: a retrospective longitudinal study
by: Ruslan Akhmedullin, et al.
Published: (2025-09-01)

Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies
by: R Prasad
Published: (2012-01-01)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
by: Andrey Maryandyshev, et al.
Published: (2017-10-01)

Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities
by: Kai Ling Chin, et al.
Published: (2024-01-01)

Re-visiting the surgical role in treating chemotherapeutic-resistance pulmonary tuberculosis: Results from a systematic review and meta-analysis
by: Majed AL-Mourgi, et al.
Published: (2025-11-01)

Treatment Outcome of Tuberculosis in HIV Seropositive Patients: An Experience of Southeast Region of Ahmedabad
by: Sanjay B Tripathi, et al.
Published: (2015-12-01)

Advances and prospects for treatment strategies of drug-resistant tuberculosis: a review
by: Michalik, Maciej, et al.
Published: (2025-06-01)

atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure
by: Laure Fournier Le Ray, et al.
Published: (2022-05-01)

Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosis
by: Tasmin Nazim, et al.
Published: (2024-01-01)

Updated treatment guidelines for drug-resistant TB: how safe are clofazimine-based regimens?
by: E. Pontali, et al.
Published: (2024-11-01)

TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia
by: Laura Gillini, et al.
Published: (2013-03-01)

QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis
by: A. V. Kukurika
Published: (2024-03-01)

Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012–2016
by: Imen Bouzouita, et al.
Published: (2019-03-01)

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
by: Heidary M, et al.
Published: (2019-11-01)